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Abstract: MUC1 is a glycoprotein that plays an important role in cancer pathogenesis. In 
order to study the effect of glycosylation on the conformational propensities of the tandem 
repeat domain of MUC1, we have determined the structure of the MUC1 tandem repeat 
peptide AHGVTSAPDTRPAPGSTAPP, O-glycosylated with the trisaccharide (?-Glc-1,4-
?-Glc-1,4-?-GalNAc-) at Thr5. This glycopeptide was synthesized to model a heavily O-
glycosylated threonine residue in the tandem repeat domain. The NMR experiments used in 
this study included TOCSY, NOESY, ROESY, DQF-COSY, HSQC and 1D NMR. The 
peak volumes determined using the program SPARKY were converted into distance 
constraints using the program CALIBA. The programs FiSiNOE and HABAS were used to 
generate angle constraints. Using conformational restraints obtained from NMR, the 
program DYANA was used to determine the structures of the peptide. Finally, structural 
refinement was performed within the SYBYL software package using GLYCAM 
parameters and Kollman-all atom types. The presence of strong sequential ?N connectivities 
suggested an extended conformation of the peptide backbone. Strong sequential ?? 
connectivities were indicative of a trans conformation of the Ala-Pro peptide bonds. In 
addition, presence of sequential NN connectivities in the peptide segments Gly3-Val4-Thr5-
Ser6, Asp9-Thr10-Arg11 and Gly-Ser16 were indicative of twist-like conformations of the 
peptide backbone in these peptide segments. 
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MUC1 [1] is a glycoprotein expressed on the cell surface of normal and cancer cells. The large 
extracellular fragment of MUC1 consists of tandem repeats of a 20 amino acid motif. Each tandem 
repeat AHGVTSAPDTRPAPGSTAPP includes two serine and three threonine residues that are 
potential sites of O-glycosylation. In normal secretory epithelial cells, MUC1 is heavily glycosylated 
and expressed on the apical surface, whereas in cancer cells MUC1 is aberrantly glycosylated and 
contributes to reconfiguration of cell-cell interactions. The altered properties of MUC1 on tumor cells 
modulate adhesion to receptors on adjoining cells and tissues thereby facilitating metastasis [2]. Thus, 
glycosylation of MUC1 plays an important role in the pathophysiology of various cancers which 
include pancreatic adenocarcinoma, lung, breast and colon cancer. 
The initiation of O-glycosylation of MUC1 in the tandem repeat domain is catalyzed by a family of 
enzymes called UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases (GalNAc transferases) 
[3-7]. Previous in vitro studies on the initiation of glycosylation of the tandem repeat domain of MUC1 
have shown that attachment of GalNAc residues to specific sites within the tandem repeat peptide of 
MUC1 facilitates glycosylation at other sites and leads to high-density glycosylation [8-10]. It has been 
hypothesized that the GalNAc transferases following initial glycosylation, bind to the GalNAc residue 
through their lectin domain, which results in conformational changes in its catalytic domain or in the 
acceptor substrate peptide backbone that facilitate glycosylation at proximal and distant sites [9]. In 
order to characterize the conformational changes on acceptor substrates that take place following initial 
glycosylation, previous studies were focused on MUC1-based tandem repeat peptides 
monoglycosylated with a single GalNAc residue at Thr5 [11]. We extended those studies to 
glycosylation of tandem repeat peptides with bulky carbohydrate moieties. Using NMR, we have 
investigated the structure of a MUC1-based tandem repeat peptide O-glycosylated with the 
trisaccharide (?-Glc-1,4-?-Glc-1,4-?-GalNAc-) at Thr5. The trisaccharide ?-Glc-1,4-?-Glc-1,4-?-
GalNAc was designed to mimic natural glycoforms that glycosylate the tandem repeat domain of 
MUC1.  
 
Materials and Methods  
Total correlation spectroscopy (TOCSY), nuclear Overhauser enhancement spectroscopy (NOESY), 
double quantum filtered correlation spectroscopy (DQF-COSY), 1D NMR, and heteronuclear single 
quantum coherence (HSQC) NMR experiments were used to obtain structural data on the peptide. All 
data were acquired on a 600 MHz Varian INOVA spectrometer operating at 14.1 Tesla. The sample 
was dissolved in 90:10 H2O:D2O to a concentration of 3mM at pH 4.5 and the data were acquired at a 
sample temperature of 5oC. Water suppression was accomplished by using presaturation (50 Hz field) 
except for the HSQC experiment, which used pulsed field gradient solvent suppression. NMR data 
were apodized by a Gaussian function and processed using VNMR software (Varian, Palo Alto, CA). 
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Sequential resonance assignments of protons [12] in the glycopeptide were obtained using the 
TOCSY and NOESY spectra. 3JN? vicinal coupling constants were obtained using the DQF-COSY 
spectra. In addition to data obtained from the NOESY and TOCSY spectra, the HSQC spectrum was 
used to assist resonance assignments of protons in the trisaccharide. The peak intensities in the 
NOESY spectrum (200 ms) were integrated using the Gaussian fit method implemented in the program 
SPARKY [13]. The peak integrals were input into the program CALIBA [14] to obtain upper distance 
constraints. The distance constraints and coupling constants were used by the programs FiSiNOE [15] 
and HABAS [16] to generate ?, ?, and ?1 torsion angle constraints and stereospecific assignments. 
Additional stereospecific assignments for ?-methylene protons were obtained using the program 
GLOMSA [14]. A model of the peptide AHGVTSAPDTRPAPGSTAPPA, O-glycosylated with the 
trisaccharide (?-Glc-1,4-?-Glc-1,4-?-GalNAc-) at Thr5, was created within the software package 
SYBYL (version 6.6) [17] using Kollman forcefield [18] and Glycam parameters [19]. The torsion 
angle constraints, distance constraints, and stereospecific assignments were used by the program 
DYANA [20] within SYBYL to generate 100 structures of the glycopeptide that were further subjected 
to constrained energy minimization. In order to determine specific conformational features of the 
peptide segment GVTSA, which contains the glycosylated Thr and flanking residues, the 100 energy-
minimized structures were clustered together using a root-mean-square-deviation (RMSD) criterion of 
0.6 Å for the backbone N, C? and C atoms. The conformational propensities of individual amino acid 
residues in the peptide segment GVTSA were determined by their relative occupancy in different 
regions of the Ramachandran plot [21, 22].  
 
Results and Discussion
NOE Connectivities and Coupling Constants 
Figure 1 shows the summary of sequential connectivities observed in the peptide backbone. These 
data indicate strong to medium sequential ?N NOE connectivities between majority of the amino acid 
residues. Strong sequential ?? connectivities within the dipeptide segments Xxx-Pro and absence of 
sequential ?? connectivities were indicative of a trans conformation for these dipeptide segments [12]. 
Abundant ?N sequential connectivities suggest that at least some or a majority of the conformers of the 
glycopeptide exist in solution having extended conformations of the peptide backbone. However, the 
presence of weak to medium sequential NN connectivities in the peptide segments Gly3-Val4-Thr5*-
Ser6 (* = ?-Glc-1,4-?-Glc-1,4-?-GalNAc-), Asp9-Thr10-Arg11 and Gly15-Ser16 (Figures 1 and 2), 
indicates that a significant population of conformers have twist-like conformations of the peptide 
backbone in these peptide segments. The absence of medium-range NOEs in the peptide excludes the 
presence of tight turns or ?-helical structures in the peptide backbone. Thus, the majority of 
conformers of the glycopeptide exist in solution in a dynamic equilibrium between extended and twist-
like conformations for the peptide segments GVSTA, DTR and GS. 




Figure 1. Summary of sequential NOE connectivities and coupling constants observed between amino 




Figure 2. A section of the 200 ms NOESY spectra of the glycopeptide showing sequential amide-
amide cross peaks (HN = amide proton of the amino acid residues, HAC = amide proton of the N-
acetyl group in the ?-GalNAc residue). 
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The degenerate chemical shifts of ?H and NH protons of His2, Thr5, Ser6, Ala7, Val4, and Thr10 
precluded the determination of 3JN? ?coupling constants for these amino acid residues. The coupling 
constants for the remaining amino acid residues ranged from 6.2 – 8.5 Hz and did not provide any 
evidence for the presence of ordered secondary structures in the peptide backbone.  
 
?H Chemical Shift Deviations for the Glycopeptide 
The ?H proton chemical shift deviations of amino acid residues from their corresponding random 
coil values [23], provides an indication of specific secondary structures in peptides and proteins. A 
summary of the chemical shift deviations of the amino acid residues in the glycopeptide is shown in 
Figure 3. Val4 and Thr5 showed significant downfield deviations (~0.3 ppm) in ?H chemical shifts 
from random coil values. These deviations in chemical shifts from random coil values were probably 
caused by local conformational effects induced by the glycosylation at Thr5. In general, despite the 
presence of amino acids having significant deviation of chemical shifts from the random coil values, 
the lack of a dense grouping of amino acids with significant downfield or upfield shifts suggests the 
absence of ordered secondary structures, such as ?-helices or ?-strands in the peptide backbone.  
 
 
Figure 3. ?H chemical shift deviations of amino acid residues in the glycopeptide from their 
corresponding random coil values (* = ?-Glc-1,4-?-Glc-1,4-?-GalNAc-). 
 
Sugar-peptide NOE Connectivities for the Glycopeptide 
The sugar-peptide NOE connectivities observed in the NOESY spectrum of the glycopeptide are 
represented in Figure 4. Several strong, medium and weak NOEs were observed between protons in 
the side chain of Thr5 and protons in the ?-GalNAc residue. In addition, weak NOEs were observed 
between protons in ?-GalNAc residue and protons in the peptide backbone. A weak NOE was 
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observed between the amide proton in the ?-GalNAc residue and the amide proton of glycosylated 
Thr5 in the peptide backbone. The weak NOE between methyl group in ?-GalNAc and ?H proton of 
Ser6 and the medium NOE between H3 proton of ?-GalNAc and NH proton of Ala7 indicate that the 
trisaccharide is oriented towards the C-terminus of the peptide backbone. These sugar-peptide 
interactions may mediate local conformational changes in the peptide segment GVTSA following 
glycosylation with the trisaccharide. These sugar-peptide interactions may also provide a local 
stabilizing effect for the peptide segment GVTSA. The trisaccharide ?-Glc-1,4-?-Glc-1,4-?-GalNAc- 
due to its orientation towards the C-terminus of the peptide backbone may hinder addition of sugar 
residues by glycosyltransferases to the side chain of adjacent Ser6. However, our structural studies 
indicated that the side chains of Thr5 and Ser6 were facing away from each other. Hence, this 
orientation of the side chains may facilitate glycosylation of both residues with extended glycans by 
different glycosyltransferases.  
 
Figure 4. Schematic diagram showing connectivities between protons of ?-GalNAc residue in the 
trisaccharide and protons of the amino acid residues in the peptide segment VTSA (H1, H2, H3, H4, 
H5, H61, H62 = protons of ?-GalNAc residue, Q3AC = methyl group pseudo atom in the N-acetyl 
group, QQG = pseudo atom at the center of two methyl groups in Val4, QG2 = pseudo atom at the 
center of the methyl group in Thr5, HAC = amide proton in the N-acetyl group, HA = ? proton in the 
peptide backbone, H = amide proton in the peptide backbone). 
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Cluster Analysis of the Peptide Segment GVTSA 
In order to determine structural features of the peptide segment GVTSA, we clustered all 
conformers of the glycopeptide at the segment GVTSA using an RMSD criterion of 0.6 Å for 
backbone atoms N, C?, and C. The clustering of conformers resulted in three distinct clusters 
containing 25%, 45%, and 16% (Clusters 1, 2, and 3) of the conformers and several small clusters with 
1-4 conformers. In order to determine distinct conformational propensities of individual amino acid 
residues in the peptide segment GVTSA, the average structures of the conformers in each cluster were 
calculated. The ? and ? torsion angles values (in degrees) for each amino acid residue in the average 
structure of the peptide segment GVTSA in each cluster were determined (Table 1).  
In the peptide segment GVTSA, Val4 showed conformational propensities for the extended ?-
strand-like and inverse ? turn-like regions of the Ramachandran plot. Thr5 and Ala7 showed 
conformational propensities for regions corresponding to extended ?-strand-like conformations, 
whereas Ser6 showed conformational propensities for regions corresponding to extended ?-strand-like 
or polyproline II-like conformations.  
In order to determine the effects of extensive glycosylation on the conformational propensities of 
the peptide backbone, further studies will be focused on peptides that will be glycosylated with 
trisaccharides at other potential sites of O-glycosylation in the tandem repeat domain, which include 
Thr10 in the PDTR and Thr17 in the GSTA region. These conformational studies together with in vitro 
kinetic and affinity studies for these glycopeptides will provide important insights into the regulation 
of glycosylation of the tandem repeat domain of MUC1.  
 
Table 1. Values of the torsion angles ? and ? (in degrees) of amino acid residues in the average 
structure of each cluster for the peptide segment GVTSA. 
 Gly3 Val4 Thr5 Ser6 Ala7 
 ? ? ?? ? ? ? ? ? ? ? 
Cluster1 171 –157 –56 113 –109 121 –142 131 –94 164 
Cluster2 –152 –136 –83 75 –117 117 –128 134 –103 139 




We are very grateful to Dr. M. Cudic and Dr. L. Otvos, Jr. (The Wistar Institute) for providing the 
glycopeptide. This work was supported by the NIH Grant 1R01 CA84106 to S.S. The Bioinformatics 
Core Facility of the UNMC Eppley Cancer Center used in this work was partially supported by the 
NIH Cancer Center Support grant P30 CA36727 and by the NIH grant RR15635 from the COBRE 
Program of the National Center for Research Resources. The NMR lab was partially supported by the 
Cancer Center Support Grant. 




1. Lan, M. S.; Batra, S. K.; Qi, W. N.; Metzgar, R. S.; Hollingsworth, M. A. Cloning and sequencing 
of a human pancreatic tumor-mucin cDNA. J. Biol. Chem. 1990, 265, 15294-15299.  
2. McDermott, K. M.; Crocker, P. R.; Harris, A.; Burdick, M. D.; Hinoda, Y.; Hayashi, T.; Imai, K.; 
Hollingsworth, M. A. Overexpression of MUC1 reconfigures the binding properties of tumor 
cells. Int. J. Cancer 2001, 94, 783-791.  
3. Wandall, H. H.; Hassan, M.; Mirgorodskaya, F.; Kristensen, A. K.; Roepstorff, P.; Bennett, E. P.; 
Nielsen, P. A.; Hollingsworth, M. A.; Burchell, J.; Taylor Papadimitriou, J.; Clausen, H. 
Specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine: Polypeptide 
N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J. Biol. Chem. 1997, 272, 
23503-23514. 
4. Stadie, T.; Chai, W.; Lawson, A. M.; Byfield, P.; Hanisch, F. G. Studies on the order and site-
specificity of GalNAc-transfer to MUC1 tandem repeats by UDP-GalNAc: polypeptide N-
acetylgalactosaminyltransferase from milk or mammary carcinoma cells. J. Biol. Chem. 1995, 
274, 27867-27874. 
5. Nishimori, I.; Johnson, N. R.; Sanderson, S. D.; Perini, R.; Mountjoy, K.; Cernag, R. L.; Gross, 
M. L.; Hollingsworth, M. A. Influence of acceptor substrate primary amino acid sequence on the 
activity of human UDP-N-acetylgalactosamine: polypeptide N-acetylgalactosaminyltransferase. 
Studies with the MUC1 tandem repeat. J. Biol. Chem. 1994, 269, 16123-16130. 
6. Bennett, E. P.; Hassan, H.; Mandel, U.; Hollingsworth, M. A.; Akisawa, N.; Ikematsu, Y.; Merkx, 
G.; van Kessel, A. G.; Olofsson, S.; Clausen, H. Cloning and characterization of a close 
homologue of human UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferase-T3, 
designated GalNAc-T6. Evidence for genetic but not functional redundancy. J. Biol. Chem. 1998, 
274, 25362-25370. 
7. Hanisch, F. G.; Muller, S.; Hassan, H.; Clausen, H.; Zachara, N.; Gooley, A. A.; Paulsen, H.; 
Alving, K.; Peter-Katalinic, J. Dynamic epigenetic regulation of initial O-glycosylation by UDP-
N-Acetylgalactosamine: Peptide N-acetylgalactosaminyl- transferases. Site-specific glycosylation 
of MUC1 repeat peptide influences the substrate qualities at adjacent or distant Ser/Thr positions. 
J. Biol. Chem. 1999, 274, 9946-9954. 
8. Bennett, E. P.; Hassan, H.; Hollingsworth, M. A.; Clausen, H. A novel human UDP-N-acetyl-D-
galactosamine: polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for 
partial GalNAc- glycosylated acceptor substrates. FEBS Lett. 1999, 460, 226–230.  
9. Hassan, H.; Reis, C.; Bennett, E. P.; Mirgorodskaya, E.; Roepstorff, P.; Hollingsworth , M. A.; 
Burchell, J.; Taylor-Papadimitriou, J.; Clausen, H. The lectin domain of UDP-N-acetyl-D-
galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide 
specificities. J. Biol. Chem. 2000, 275, 38197–38205.  
10. Hanisch, F. G.; Reis C. A.; Clausen, H.; Paulsen, H. Evidence for glycosylation- dependent 
activities of polypeptide N-acetylgalactosaminyltransferases rGalNAc-T2 and -T4 on mucin 
glycopeptides. Glycobiology 2001, 11, 731-740.  
11. Kirnarsky, L.; Prakash, O.; Vogen, S. M.; Nomoto, M.; Hollingsworth, M. A.; Sherman, S. 
Structural effects of O-glycosylation on a 15-residue peptide from the mucin (MUC1) core 
protein. Biochemistry 2000, 39, 12076-12082. 
Int. J. Mol. Sci. 2004, 5   
 
92
12. Wüthrich, K. NMR of proteins and nucleic acids, John Wiley and Sons, New York, 1986. 
13. Goddard, T. D.; Kneller, D. G. SPARKY 3, University of California, San Francisco. 
14. Güntert, P.; Braun, W.; Wüthrich, K. Efficient computation of three-dimensional protein 
structures in solution from nuclear magnetic resonance data using the program DIANA and the 
supporting programs CALIBA, HABAS and GLOMSA. J. Mol. Biol. 1991, 217, 517-530. 
15. Shats, O.; Sherman, S. The FiSiNOE-3 Program for Determination of Protein and Peptide 
Conformations from NMR Data. Third Electronic Computational Chemistry Conference (ECCC-
3) 1996, http://bims.unmc.edu/ECCC3/fisinoe3.htm 
16. Güntert, P.; Wüthrich, K. Automated Stereo Specific 1H NMR Assignments and their Impact on 
the Precision of Protein Structure Determinations. J. Am. Chem. Soc. 1989, 111, 3997-4004. 
17. Tripos Associates, St. Louis, version 6.6. 
18. Weiner, S. J.; Kollman, P. A.; Case, D. A.; Singh, U. C.; Ghio, C.; Alagona, G.; Profeta, S. Jr.; 
Weiner, P. A New Forcefield for Molecular Mechanical Simulation of Nucleic Acids and 
Proteins. J. Am. Chem. Soc. 1984, 106, 765-784. 
19. Woods, R. J.; Edge, C. J.; Wormald, M. R.; Dwek, R. A. A generalized parameter set for 
molecular dynamics simulations of glycoproteins and oligosaccharides. Application to the 
structure and dynamics of a disaccharide related to oligomannose. In Complex Carbohydrates in 
Drug Research; Bock, K.; Clausen, H.; Krogsagaard-Larsen, P.; Kofod, H.; Eds.; Alfred Benzon 
Symposium 1993, 36, 15-26. 
20. Güentert, P.; Mumenthaler, C.; Wüthrich, K. Torsion angle dynamics for NMR structure 
calculation with the new program DYANA. J. Mol. Biol. 1997, 273, 283-298. 
21. Rubinstein, A.; Shats, O.; Sherman, S. Role of the Local Interactions in Intrinsic Conformational 
and Structural Propensitites of Amino Acid Residues in Proteins. Seventh Electronic 
Computational Chemistry Conference (ECCC-7), 2001, http://bims.unmc.edu/ECCC7. 
22. Ramachandran, G. N.; Ramakrishnan, C.; Sasisekharan, V. Stereochemistry of polypeptide chain 
conformations. J. Mol. Biol. 1963, 7, 95-99. 
23. Wishart, D. S.; Sykes, B. D.; Richards, F. M. The chemical shift index: a fast and simple method 
for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry  
1992, 31, 1647-1651. 
 
 
© 2004 by MDPI (http://www.mdpi.net). Reproduction for noncommercial purposes permitted. 
 
